Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2023
DOI: 10.3390/nu15081884
|View full text |Cite
|
Sign up to set email alerts
|

Associations of VEGF-A-Related Variants with Adolescent Cardiometabolic and Dietary Parameters

Abstract: Previous research has allowed the identification of variants related to the vascular endothelial growth factor-A (VEGF-A) and their association with anthropometric, lipidemic and glycemic indices. The present study examined potential relations between key VEGF-A-related single-nucleotide polymorphisms (SNPs), cardiometabolic parameters and dietary habits in an adolescent cohort. Cross-sectional analyses were conducted using baseline data from 766 participants of the Greek TEENAGE study. Eleven VEGF-A-related S… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 49 publications
0
3
0
Order By: Relevance
“…Thus, by utilizing a lipid genetic score constructed from genetic variations associated with VEGFA, our study extended its inquiry, shedding light on a causal link between lipid metabolism and CVD risk. Previous research has firmly established the additional CVD risk associated with pathogenic FH variations (64)(65)(66). Currently, statins, ezetimibe, bile acid sequestrants, and PCSK9 inhibitors are used as standard agents for lipid-lowering interventions.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, by utilizing a lipid genetic score constructed from genetic variations associated with VEGFA, our study extended its inquiry, shedding light on a causal link between lipid metabolism and CVD risk. Previous research has firmly established the additional CVD risk associated with pathogenic FH variations (64)(65)(66). Currently, statins, ezetimibe, bile acid sequestrants, and PCSK9 inhibitors are used as standard agents for lipid-lowering interventions.…”
Section: Discussionmentioning
confidence: 99%
“…Notably, these genes have a gene-by-environment phenomenon, i.e., they can only proxy alcohol intake among ever drinkers but would not work among never drinkers [14]. Kafyra et al examined the interactions between vascular endothelial growth factor A (VEGFA) gene and dietary patterns, and explored their associations with cardiometabolic factors among 766 participants in Greek TEENAGE study [15]. Gene-byenvironment MR has been further developed to use offspring genotypes as proxies for unmeasured maternal genotypes, in order to explore offspring intrauterine exposures on their later life outcomes [16].…”
Section: Human Geneticsmentioning
confidence: 99%
“…VEGF is part of the classical angiogenic factors that mediate atherosclerotic angiogenesis, in addition to its role in neovascularization, plaque growth/progression, and instability [25]. VEGF has a multifactorial influence on energy homeostasis, the lipidemic profile, insulin resistance, glucose sensitivity, and cardiac function [189]. The effects of VEGFs on the development of atherosclerosis are complex and diverse, but VEGF-A prevents the repair of endothelial damage, contributing to atherogenesis and promoting monocyte adhesion, transendothelial migration, and activation [188].…”
Section: Vegf/vegfr In Atherosclerosismentioning
confidence: 99%